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OBJECTIVE: To determine long-term survival, identify preoperative factors predictive of a favorable outcome, and assess func-
tional improvement after coronary artery bypass grafting in patients with advanced left ventricular dysfunction. 
METHODS: Between 1995 and 2001, 244 patients who underwent coronary artery bypass grafting and had a preoperative left 
ventricular ejection fraction less than or equal to 35% were included. left ventricular ejection fraction was determined by uniplanar 
or biplanar ventriculography during left heart catheterization. Indication for surgery was predominance of tissue viability. Func-
tional improvement was evaluated through echocardiography and gated scintigraphy at exercise/ rest. Survival was determined by 
Kaplan-Meier analysis. 
RESULTS: Mean left ventricular ejection fraction was 29±4% (ranged from 9% to 35%). An average of 3.01 coronary bypass 
grafts per patient were performed. In-hospital mortality was 3.7% (9 patients). The 4-year survival rate was 89.7%. Multivariate 
correlates of favorable short- and long-term outcome were preoperative New York Heart Association Funcional classification for 
congestive heart failure class I/II, lower PAsP, higher left ventricular ejection fraction and gated left ventricular ejection fraction 
Ex/Rest ratio >5%. Left ventricular ejection fraction rise from 32±5% to 39±5%, p <0.001. Gated left ventricular ejection fraction 
at exercise/ rest increased markedly after surgery: from 27±8%/ 23±7% to 37±5%/ 31±6%, p <0.001. 
CONCLUSIONS: In selected patients with severe ischemic left ventricular dysfunction and predominance of tissue viability, 
coronary artery bypass grafting may be capable of implement preoperative clinical/ functional parameters in predicting outcome 
as left ventricular ejection fraction and gated left ventricular ejection fraction at exercise/ rest.
KEYWORDS: Coronary artery bypass grafting surgery. Left ventricular dysfunction. Myocardial revascularization. Functional 
improvement. Preoperative predictive factors.
INTRODUCTION
Coronary artery bypass grafting (CABG) has achieved 
a well-established role on the management of patients 
with coronary artery disease (CAD) and left ventricular 
disfunction, providing long-term benefits superior to 
medical therapy.1-5 However, when considering patients with 
severe left ventricular dysfunction (left ventricular ejection 
fraction [LVEF] <30%), such a success was obtained 4
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very gradually. Provided by the advances on preoperative 
care stabilization, such as by the prophylactic use of 
intraaortic balloon pump (IABP),6-8 on surgical technique 
by means of new cardioplegic solutions and shorter cross 
clamp and cardiopulmonary bypass times, associated 
with the improvement on intensive postoperative care, 
in-hospital mortality rates decreased about four times9-19 
during the last two decades, which makes the procedure 
a very suitable implement for the management of these 
particular population. Nevertheless, a judicious evaluation 
of preoperative clinical and functional parameters should be 
undertaken when selecting patients for surgery, especially for 
those with extremely poor function.
The present retrospective study was performed to 
determine long-term survival, identify preoperative factors 
predictive of a favorable outcome, and assess functional 
improvement after CABG in patients with advanced left 
ventricular dysfunction.
MATERIALS AND METHODS
All patients who underwent CABG between 1998 
and 2004, and who had a preoperative LVEF≤35% were 
included in this analysis. There were 153 male and 91 female 
patients. This study was approval by Ethics Committee. 
The LVEF was estimated by either uniplanar or biplanar 
ventriculography during left heart catheterization (table 1).
Data were recovered retrospect from medical records and 
congestive heart failure class were rated using classification 
of New York Heart Association.
Indication for surgery was based on predominance of 
tissue viability, defined as maintained Thallium-201 uptake 
in more than 50% of dyssynergic segments at rest.
All procedures were performed using cardiopulmonary 
bypass and hypothermia of 32° Centigrade. Roller pump and 
membrane oxygenators were used in all of these procedures. 
Distal anastomoses were performed during cross clamp time 
and aortic anastomoses were carried out using tangential aortic 
clamping with empty fibrillating or beating heart. Total number 
of grafts was 736. Mean number of grafts per patient was 3.01 
(77% with internal thoracic artery) and 17% had concomitant 
mitral valve replacement or repair (table 2). Cold crystalloid 
cardioplegia (St. Thomas solution) insertion was antegrade and 
intermittent (into grafts being already constructed). 
Patients performed bidimensional echocardiography 
and gated scintigraphy before surgery and at a median time 
of 12 months after that, in order to establish functional 
improvement.
Statistical methods
All data are presented as proportions or as mean±standard 
deviation. Comparisons of means as appropriate were 
determined by using paired t-tests. Difference of proportions 
was evaluated by using fisher exact test. Univariate analysis 
was employed to determine the association between 
concomitant variables and death. Multivariate analysis was 
performed by logistic regression analysis. Survival was 
determined by Kaplan-Meier analysis. Statistical significance 
was considered with p<0.05. All analysis were performed by 
SPSS 10.0 statistical software package. 
RESULTS
The mean age of patients was 61±7 years old. Risks 
for coronary artery disease are shown in table 1. Fifty-nine 
percent of patients had previous myocardial infarction. 
Prior revascularization and prior percutaneous transluminal 
coronary angioplasty were present in 24% and 49%, 
respectively. Seventy-two percent of patients had angina 
at the time of operation. Class III or IV of New York Heart 
Association Funcional classification for congestive heart 
failure (NYHA FCCHF) was present in more than 41% of 
patients and 87% had multivessel disease. Mean LVEF was 
29±4% (ranged from 9% to 35%) and mean LVEDP was 
32±7 mmHg (ranged from 11 to 44 mmHg). Thirty-one 
patients (12.7%) had LVEF <15%, 140 (57.4%) between 
16% and 25%, and 73 (29.9%) between 26% and 35% (table 
1). After four years of follow-up, we had 94% of patients 
included in study.
An average of 3.01 coronary bypass grafts per patient 
were performed (77% with internal thoracic artery) and 17% 
had concomitant mitral valve replacement or repair (table 2). 
Mean cardiopulmonary bypass time was 65 min (40–92), 
mean cross clamp time was 42 min (20–51).
Morbidity according to preoperative LVEF are shown 
in table 3. 
In-hospital mortality was 3.7% (9 patients). Causes of 
death included hemorrhage (4 patients), infection (3 patients) 
and myocardial infarction (2 patients). The 4-year survival 
rate was 89.7%. There were 16 (6,5%) cases of stroke in 
post-operatory. In-hospital mortality was as high as 13% for 
patients with LVEF <15%, 25% for PAsP >70mmHg, and 
10% for CHF IV patients. Kaplan-Meier survival curves 
according to preoperative parameters are shown in figure 1.
 Multivariate analysis showed positive correlation 
between favorable short and long-term outcome and 
preoperative NYHA FCCHF class I/II (p=0,0072), lower 
PAsP (p<0,0001), higher LVEF (p=0,0001), and gated 
LVEF Ex/Rest ratio >5% (p<0,0001). At a median time of 
12 months after surgery, 201 patients repeated bidimensional 
echocardiography and 173 patients performed radioisotopic 
evaluation of LVEF. LVEF rose from 32±5% to 39±5%, 5
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Table 1 - Baseline characteristics 
   n = 244
Age, y 61±7
Male sex, % 153 (62.7)
Female sex, % 91 (37.3)
Medical history, %
Hypertension 75 (30.7)
Hypercholesterolemia 82 (33.6)
Diabetes mellitus 41 (16.8)
Smoking 93 (38.1)
Previous MI 144 (59.0)
Months after MI 5.3±1.6 (2.5-49)
Site of MI, %
undefined or LBBB 62 (43)
anterior 56 (38.9)
inferior 29 (20.1)
lateral 7 (4.9)
Angina present at surgery, % 175 (71.7)
NYHA FCCHF, %
I 58 (23.8)
II 85 (34.8)
III 62 (25.4)
IV 39 (16.0)
Cine and hemodynamic data
Uniarterial, % 32 (13.1)
Biarterial, % 121 (49.6)
Triarterial, % 91 (37.3)
LVEF, % 29±4 (9-35)
SBP, mm Hg 128±21 (91-163)
DBP, mm Hg 77±11 (65-102)
PAsP, mm Hg 57±20 (24-83)
PAdP, mm Hg 29±21 (13-47)
LVEDP, mm Hg 32±7 (11-44)
Values represent means±SD unless stated otherwise. MI indicates myocardial 
infarction; LBBB, left bundle branch block; NYHA FCCHF, New York Heart 
Association Functional classification for cardiac heart failure; LVEF, left 
ventricular ejection fraction; SBP, systolic blood pressure; DBP< diastolic 
blood pressure; PasP, pulmonary artery systolic pressure; PadP; pulmonary 
artery diastolic pressure; and LVEDP, left ventricular end-diastolic pressure
Table 2 - Surgical treatment
All grafts 736
Left internal thoracic artery 189
Right internal thoracic artery 81
Radial artery 83
Safena vein 83
Grafts/ patient 3.01
Mitral valve replacement, % 30 (12.3)
Mitral valve repair, % 11 (4.5)
Table 3 - Morbidity according to preoperative LVEF
<15% 16-25% 26-35% p value*
n of patients 31 140 73
ICU length-of-stay, days 12±3 7±5 4±4 £0.001
Hospital length-of-stay, days 29±5 18±5 16±3 £0.001
Dob and/or nor use, % 31 (100) 14 (10) 22 (30.1) £0.001
ARF, % 15 (48.4) 13 (9.3) 8 (11) £0.001
Infection, % 14 (45.1) 10 (7.1) 5 (6.8) £0.001
IABP use, % 25 (80.6) 60 (42.8) 8 (11) £0.001
Values represent means±SD unless stated otherwise. Dob indicates dobu-
tamine; nor, norepinephrine; ARF, acute renal failure; IABP, intra-aortic 
balloon pump. * For means, p value calculated by ANOVA oneway test; 
for proportions, Chi-square test. Post-hoc analysis among 3 intervals: for 
means, p <0.05; for proportions, p <0.001.
p <0.001 (fig. 2). Gated LVEF at exercise/ rest increased 
markedly after surgery: from 27±8%/ 23±7% to 37±5%/ 
31±6%, p <0.001 (figure 2). Class I and II of NYHA FCCHF 
was present in 30,2% and 41,6% of patients, and Class III 
and IV in 21,2% and 7,0%, respectively.
DISCUSSION
During the last two decades, important advances on the 
management of patients with severe compromise of left 
ventricular function have remarkably altered the scenario 
of grafting as the use of IABP before operation improving 
survival and reducing hospital stay.6,20,21 Additionally, 
advances on myocardial preservation and resuscitation 
techniques, on surgical procedure by means of shorter 
cross clamp and cardiopulmonary bypass times, associated 
with the improvement on intensive postoperative care 
also collaborated significantly to that changes. Because 
of all that progress, perioperative mortality rates of 10% 
to 37%10,11 was converted to the 2.5% to 8% reported on 
recent studies.5,18,19,22-28 In spite of the severe compromise 
of left ventricular function of our patients (mean LVEF 
of 29%, ranging from 9% to 35%), we show in-hospital 
mortality lower than 4% and a 4-year survival close to 90%, 
in agreement with the current literature. About 49% and 
59% of our patients had, respectively, prior percutaneous 
transluminal coronary angioplasty and myocardial infarction. 
These data show us one more time the high rate of morbidity 
in patients included in this study.
In association to such development, careful examination 
of preoperative clinical and functional parameters also 
contributes significantly to determine survival, serving as a 
useful and valuable guide on patient selection for surgery. 
We observed that some preoperative variables expressively 
affected outcome. Multivariate analysis showed positive 6
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correlation between favorable short and long-term outcome 
and preoperative NYHA FCCHF class I/II, PAsP <50 mm 
Hg, gated LVEF exercise/ rest ratio >5% and LVEF >16%. 
Kaplan-Meier curves demonstrate a significant difference in 
survival when adjusted for each of these variables. Of note, 
this difference became apparent since the in-hospital period 
and sustained statistically significant during the 4 years of 
follow-up (figure 1). On the contrary, when considering 
the more severely ill patients, in-hospital mortality was 
as high as 13% for patients with LVEF <15%, 25% for 
PAsP >70mmHg, and 10% for NYHA FCCHF IV patients. 
Concerning clinical parameters, a report of Trachiotis and 
colleagues16 identified older age, female sex, diabetes, and 
severity of angina class, hypertension, and NYHA FCCHF 
as predictive of poor survival. Isbir and associates17 observed 
a higher mortality for patients with elevated PAP and right 
ventricular failure, and Milano et al29 noted depressed 
cardiac index and elevated LVEDP as important predictors of 
mortality. Kay and coworkers30 showed that the probabilities 
of postoperative complications are 63% and 87% greater 
for patients with LVEF between 30% and 39% and LVEF 
<30%, respectively, compared with patients with LVEF 
>40%. We observed significant higher rates of length of 
hospitalization, infection, acute renal failure, and IABP and 
vasoactive drugs use for patients with LVEF <25%. Taken 
together, these results raise two provocative issues: if there 
is a limit for CABG indication and if does exist a situation 
where it offers no overall benefit over medical therapy. 
However, they also demonstrate that preoperative clinical, 
hemodynamic, functional and angiographic parameters are 
valuable predictors of short- and long-term outcome and 
capable of interfering with the decision-making process. 
For the present, it seems reasonable to assess carefully 
preoperative factors in selection of candidates for surgical 
treatment, besides different studies have showed that in 
selected patients with the worst surgical therapy prognosis, 
medical therapy does not modify the prognosis too.5,10-12,14
Another interesting issue refers to the hypothesis of 
recruitment of the viable muscle (hibernating myocardium), 
interpreted as the ability to completely revascularize 
ischemic myocardium. We suppose it is an even more 
important factor in predicting outcome than the preoperative 
parameters themselves. Another studies revealed better 
outcomes for patients who have received a higher number 
of grafts.1,3,5,9-14,16,17 
Several studies demonstrate functional improvement 
after revascularization, either in NYHA or by means of 
echocardiography results.10,20,31 Salati and colleagues32 
observed a small but significant global myocardial 
amelioration, with a 25% rise in LVEF, especially for those 
Figure 1 - Kaplan-Meier cumulative survival curves adjusted for: (a) NYHA FCCHF; (b) PasP (mmHg); (c) LVEF; (d) GATED LVEF exercice/rest7
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